Borget I et al. - Darbepoetin alfa is an erythropoeisis-stimulating agent that can be given in an every week (QW) or every-3-weeks (Q3W) schedule for the treatment of chemotherapy-induced anemia. The Q3W schedule is cost saving compare to the QW schedule. It also reduces the burden of the frequent visits for the patients.